Scott Eisenbeis
7Patents
4h-index
15Co-inventors
50Inventor score
Filing activity: Oct 29, 1993 → Jul 28, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5795718A | Detection of complementary nucleotide sequences | Chemistry; Metallurgy | 26 | Expired |
| US8481022B2 | Method of treating autoimmune disease with mesenchymal stem cells | Chemistry; Metallurgy | 10 | Active |
| US5492813A | Muteins of .beta.-galactosidase fragments having increased activity | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5464747A | Oxidation-resistant muteins of .beta.-galactosidase fragments | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5976857A | Cross-linked polypeptide fragments of .beta.-galactosidase | Chemistry; Metallurgy | 3 | Expired |
| US5763196A | Assays using cross-linked polypeptide fragments of .beta.-galactosidase | Chemistry; Metallurgy | 3 | Expired |
| US8758761B2 | Combination therapies for treating type 1 diabetes | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.